Search research articles
Contact Us
Filters
Showing results (1-10 of 66) with videos related to
Page
of 7
Sort By:
Biomedicines
|
February 26, 2025
Perspectives, Challenges, and Advances in Therapeutic Strategies for Gynecological Malignant Tumors
Alberto Farolfi, Daniela Montanari, Chiara Casadei, et al.
Expert Opinion on Pharmacotherapy
|
December 27, 2013
Palbociclib (PD 0332991) : targeting the cell cycle machinery in breast cancer
Andrea Rocca, Alberto Farolfi, Sara Bravaccini, et al.
Tumori
|
April 4, 2013
Metastatic bone disease in the era of bone-targeted therapy: clinical impact
Toni Ibrahim, Alberto Farolfi, Laura Mercatali, et al.
Oncology Research
|
June 26, 2026
Progression-Free Survival with PARP Inhibitors According to Clinical Risk in Patients with Ovarian Cancer: An Indirect Comparison Using Reconstructed Data
Lorenzo Gasperoni, Luna Del Bono, Alberto Farolfi, et al.
International Journal of Molecular Sciences
|
November 9, 2024
Treatment Strategies for Advanced Endometrial Cancer According to Molecular Classification
Valentina Tuninetti, Alberto Farolfi, Chiara Rognone, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
July 25, 2016
Pharmacokinetics, pharmacodynamics and clinical efficacy of nivolumab in the treatment of metastatic renal cell carcinoma
Alberto Farolfi, Giuseppe Schepisi, Vincenza Conteduca, et al.
Oncotarget
|
November 9, 2017
Resource utilization and cost saving analysis of subcutaneous versus intravenous trastuzumab in early breast cancer patients
Alberto Farolfi, Paolo Silimbani, Davide Gallegati, et al.
Therapeutic Advances in Medical Oncology
|
February 17, 2017
Progress with palbociclib in breast cancer: latest evidence and clinical considerations
Andrea Rocca, Alessio Schirone, Roberta Maltoni, et al.
Oncology
|
December 22, 2012
Hormonal receptor, human epidermal growth factor receptor-2, and Ki67 discordance between primary breast cancer and paired metastases: clinical impact
Toni Ibrahim, Alberto Farolfi, Emanuela Scarpi, et al.
Critical Reviews in Oncology/Hematology
|
July 11, 2020
A comprehensive review of the role of immune checkpoint inhibitors in elderly patients affected by renal cell carcinoma
Cristian Lolli, Amelia Altavilla, Vincenza Conteduca, et al.
Page
of 7
Search research articles
Search
Showing results (1-10 of 66) with videos related to
Sort By:
Page
of 7
Biomedicines
|
February 26, 2025
Perspectives, Challenges, and Advances in Therapeutic Strategies for Gynecological Malignant Tumors
Alberto Farolfi, Daniela Montanari, Chiara Casadei, et al.
Expert Opinion on Pharmacotherapy
|
December 27, 2013
Palbociclib (PD 0332991) : targeting the cell cycle machinery in breast cancer
Andrea Rocca, Alberto Farolfi, Sara Bravaccini, et al.
Tumori
|
April 4, 2013
Metastatic bone disease in the era of bone-targeted therapy: clinical impact
Toni Ibrahim, Alberto Farolfi, Laura Mercatali, et al.
Oncology Research
|
June 26, 2026
Progression-Free Survival with PARP Inhibitors According to Clinical Risk in Patients with Ovarian Cancer: An Indirect Comparison Using Reconstructed Data
Lorenzo Gasperoni, Luna Del Bono, Alberto Farolfi, et al.
International Journal of Molecular Sciences
|
November 9, 2024
Treatment Strategies for Advanced Endometrial Cancer According to Molecular Classification
Valentina Tuninetti, Alberto Farolfi, Chiara Rognone, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
July 25, 2016
Pharmacokinetics, pharmacodynamics and clinical efficacy of nivolumab in the treatment of metastatic renal cell carcinoma
Alberto Farolfi, Giuseppe Schepisi, Vincenza Conteduca, et al.
Oncotarget
|
November 9, 2017
Resource utilization and cost saving analysis of subcutaneous versus intravenous trastuzumab in early breast cancer patients
Alberto Farolfi, Paolo Silimbani, Davide Gallegati, et al.
Therapeutic Advances in Medical Oncology
|
February 17, 2017
Progress with palbociclib in breast cancer: latest evidence and clinical considerations
Andrea Rocca, Alessio Schirone, Roberta Maltoni, et al.
Oncology
|
December 22, 2012
Hormonal receptor, human epidermal growth factor receptor-2, and Ki67 discordance between primary breast cancer and paired metastases: clinical impact
Toni Ibrahim, Alberto Farolfi, Emanuela Scarpi, et al.
Critical Reviews in Oncology/Hematology
|
July 11, 2020
A comprehensive review of the role of immune checkpoint inhibitors in elderly patients affected by renal cell carcinoma
Cristian Lolli, Amelia Altavilla, Vincenza Conteduca, et al.
Page
of 7